Research projects
Cima Universidad de Navarra
-
Heart FailureCompleted
MINERVA II Project: cardIoreNal pERsonalized cardIoreNal Medicine in NaVArrA
Cima Principal Investigator: Arantxa González Miqueo [SP]Funder: Gobierno de NavarraAward year 2021 -
Heart FailureCompleted
ICI20/00011 Prospective, multicenter, open-label study to evaluate the efficacy of esmolol in the early identification of cardiovascular disorders induced by cirrhosis, diabetes mellitus and cardiotoxic treatments (bB-ECHO).
Cima Principal Investigator: Arantxa González Miqueo [SP] [SP]Funder: Instituto de Salud Carlos III -
Heart FailureCompleted
PI20/01319 Identification of a biomarker-based molecular fingerprint of heart failure with chronic kidney disease. Potential mechanistic, prognostic and therapeutic implications
Cima Principal Investigator: Susana Ravassa Albéniz [SP]Funder: Instituto de Salud Carlos III -
Heart FailureCompleted
Prevalence of cardiac sequelae after SARS-CoV-2 infection. CAR-VID study
Cima Principal Investigator: Begoña López SalazarFunder: Fundación Francisco Soria-Melguizo -
Heart FailureCompleted
SC1-BHC-01-2019-848109-2 MiCrovasculaR rarefaction in vascUlar Cognitive Impairment and heArt faiLure (CRUCIAL)
Cima Principal Investigator: Arantxa González Miqueo [SP] [SP] [SP]Funder: Comisión Europea, Programa H2020 -
Heart FailureCompleted
PC056-057-058 CESAR Characterization of a noninvasive biomarker profile associated with cardiac damage in SARS-CoV-2 infected patients. Diagnostic and prognostic implications
Cima Principal Investigator: Begoña López SalazarFunder: Gobierno de Navarra -
Heart FailureCompleted
2/2019 Analysis of the usefulness of electro-anatomical characterization of the left atrium and the use of circulating biomarkers of myocardial fibrosis
Cima Principal Investigator: Susana Ravassa Albéniz [SP] [SP]Funder: Gobierno de Navarra -
Heart FailureCompleted
PI18/01469 Effects of sodium-glucose cotransporter-2 inhibition on the mechanisms of cardiac damage in diabetic patients with heart failure and preserved ejection fraction
Cima Principal Investigator: Arantxa González Miqueo [SP] [SP] [SP] [SP]Funder: Instituto de Salud Carlos III -
Heart FailureCompleted
0011-1411-2018-000043 Genomic study for personalizing diagnosis and treatment of patients with chronic heart failure and chronic kidney disease
Cima Principal Investigator: Javier Díez Martínez [SP]Funder: Gobierno de Navarra -
Heart FailureCompleted
PI17/01999 Study of myocardial interstitial fibrosis in cardiac toxicity associated with breast cancer treatment. Diagnostic and therapeutic implications
Cima Principal Investigator: Susana Ravassa Albéniz [SP] [SP] [SP]Funder: Instituto de Salud Carlos III